Literature DB >> 1915241

Analysis of cerebrospinal fluid from patients with psychiatric and neurological disorders by two-dimensional electrophoresis: identification of disease-associated polypeptides as fibrin fragments.

D B Wildenauer1, D Körschenhausen, W Hoechtlen, M Ackenheil, M Kehl, F Lottspeich.   

Abstract

Two-dimensional electrophoresis (2-DE) of cerebrospinal fluid (CSF) samples--from 347 patients with various psychiatric and neurological disorders--and subsequent silver staining revealed two additional polypeptides (Mr 40,000) in 49% of 111 schizophrenics, 46% of 43 schizoaffective patients, 36% of 41 patients with affective disorders, 43% of 28 patients with multiple sclerosis, but not in 25 patients without neurological symptomatology, nor in 9 patients with Lues, and in only 2 of 25 patients with AIDS. The two polypeptides, as detected by 2-DE, eluted after size exclusion chromatography in fractions containing proteins with Mr greater than 200,000. After 2-DE of CSF samples, enriched by gel chromatography, the polypeptides were immobilized by blotting onto glass-fiber membranes and subjected to N-terminal sequencing. Polypeptide A was identified as beta-chain remnant (beta 2), derived from plasmin cleavage of fibrin(ogen). After size exclusion chromatography, 2-DE, and Western blotting, polypeptide A and B, as well as several other spots, reacted with fibrinogen antibodies, suggesting that the polypeptides are subunits of a fibrin degradation complex.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1915241     DOI: 10.1002/elps.1150120706

Source DB:  PubMed          Journal:  Electrophoresis        ISSN: 0173-0835            Impact factor:   3.535


  8 in total

1.  Two-dimensional fluorescence difference gel electrophoresis for comparative proteomics profiling.

Authors:  Nilesh S Tannu; Scott E Hemby
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

2.  Variations in the cerebrospinal fluid proteome following traumatic brain injury and subarachnoid hemorrhage.

Authors:  David E Connor; Ganta V Chaitanya; Prashant Chittiboina; Paul McCarthy; L Keith Scott; Lisa Schrott; Alireza Minagar; Anil Nanda; J Steven Alexander
Journal:  Pathophysiology       Date:  2017-05-13

3.  A Panel of Exosome-Derived miRNAs of Cerebrospinal Fluid for the Diagnosis of Moyamoya Disease.

Authors:  Gang Wang; Yunyu Wen; Oluwasijibomi Damola Faleti; Qingshun Zhao; Jingping Liu; Guozhong Zhang; Mingzhou Li; Songtao Qi; Wenfeng Feng; Xiaoming Lyu
Journal:  Front Neurosci       Date:  2020-09-25       Impact factor: 4.677

Review 4.  Inflammation in Schizophrenia: Pathogenetic Aspects and Therapeutic Considerations.

Authors:  Norbert Müller
Journal:  Schizophr Bull       Date:  2018-08-20       Impact factor: 9.306

Review 5.  Coagulation Pathways in Neurological Diseases: Multiple Sclerosis.

Authors:  Nicole Ziliotto; Francesco Bernardi; Dejan Jakimovski; Robert Zivadinov
Journal:  Front Neurol       Date:  2019-04-24       Impact factor: 4.003

Review 6.  Kynurenines and the Endocannabinoid System in Schizophrenia: Common Points and Potential Interactions.

Authors:  Ferenc Zádor; Gábor Nagy-Grócz; Gabriella Kekesi; Szabolcs Dvorácskó; Edina Szűcs; Csaba Tömböly; Gyongyi Horvath; Sándor Benyhe; László Vécsei
Journal:  Molecules       Date:  2019-10-15       Impact factor: 4.411

7.  The proteome of human brain microdialysate.

Authors:  Martin H Maurer; Christian Berger; Margit Wolf; Carsten D Fütterer; Robert E Feldmann; Stefan Schwab; Wolfgang Kuschinsky
Journal:  Proteome Sci       Date:  2003-12-14       Impact factor: 2.480

Review 8.  The role of inflammation in schizophrenia.

Authors:  Norbert Müller; Elif Weidinger; Bianka Leitner; Markus J Schwarz
Journal:  Front Neurosci       Date:  2015-10-21       Impact factor: 4.677

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.